Novo Nordisk A/S
(OTCPK:NONOF)
$
133.128
0.718 (0.54%)
Market Cap: 589.32 Bil
Enterprise Value: 588.71 Bil
PE Ratio: 46.07
PB Ratio: 40.96
GF Score: 92/100 
Q1 2024 Novo Nordisk A/S Earnings Call (London-Based Investors) TranscriptMay 03, 2024$121.51 (-2.18%)Earnings- Q1 2024 Novo Nordisk A/S Earnings Call TranscriptMay 02, 2024$124.22 (-1.77%)Earnings
- Novo Nordisk A/S Annual Shareholders Meeting TranscriptMar 21, 2024
- Novo Nordisk A/S Capital Markets Day TranscriptMar 07, 2024
- Q4 2023 Novo Nordisk A/S Earnings Call (London-Based Investors) TranscriptFeb 01, 2024$115.39 (+0.06%)Earnings
- Q4 2023 Novo Nordisk A/S Earnings Call TranscriptJan 31, 2024$115.31 (+3.98%)Earnings
- Novo Nordisk A/S at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Novo Nordisk A/S at American Heart Association Conference TranscriptNov 11, 2023
- Q3 2023 Novo Nordisk A/S Earnings Call (London-Based Investors) TranscriptNov 03, 2023$97.62 (-4.21%)Earnings
- Q3 2023 Novo Nordisk A/S Earnings Call TranscriptNov 02, 2023$101.91 (+6.11%)Earnings
- Q2 2023 Novo Nordisk A/S Earnings Call (London-Based Investors) TranscriptAug 11, 2023$91.38 (+0.14%)Earnings
- Q2 2023 Novo Nordisk A/S Earnings Call TranscriptAug 10, 2023$91.25 (-3.07%)Earnings
- Novo Nordisk A/S R&D Investor Call TranscriptJun 26, 2023
- Q1 2023 Novo Nordisk A/S Earnings Call (London-Based Investors) TranscriptMay 09, 2023$84 (+0.26%)Earnings
- Q1 2023 Novo Nordisk A/S Earnings Call TranscriptMay 04, 2023$79.97 (-3.78%)Earnings
- Novo Nordisk A/S Annual Shareholders Meeting TranscriptMar 23, 2023
- Q4 2022 Novo Nordisk A/S Earnings Call TranscriptFeb 01, 2023$68.79 (-1.02%)Earnings
- Q3 2022 Novo Nordisk A/S Earnings Call (London-Based Investors) TranscriptNov 03, 2022$55.6 (+0.02%)Earnings
- Q3 2022 Novo Nordisk A/S Earnings Call TranscriptNov 02, 2022$55.58 (+2.34%)Earnings
- Novo Nordisk A/S at JPMorgan CEO Call Series TranscriptSep 14, 2022
- Q2 2022 Novo Nordisk A/S Earnings Call (London-Based Investors) TranscriptAug 05, 2022$51.21 (-1.50%)Earnings
- Q2 2022 Novo Nordisk A/S Earnings Call TranscriptAug 03, 2022$50.4 (-11.87%)Earnings
- Novo Nordisk A/S Investor and Analyst Event at ADA TranscriptJun 06, 2022
- Q1 2022 Novo Nordisk A/S Earnings Presentation - London TranscriptMay 05, 2022
- Q1 2022 Novo Nordisk A/S Earnings Call TranscriptApr 29, 2022$56.25 (+2.72%)Earnings
- Novo Nordisk A/S Annual Shareholders Meeting TranscriptMar 24, 2022
- Novo Nordisk A/S Capital Markets Day TranscriptMar 03, 2022
- Q4 2021 Novo Nordisk A/S Earnings Call (London-Based Investors) TranscriptFeb 04, 2022$49.22 (-7.07%)Earnings
- Q4 2021 Novo Nordisk A/S Earnings Call TranscriptFeb 02, 2022$53.96 (+6.85%)Earnings
- Novo Nordisk A/S to Discuss Supply Challenges for Wegovy Call TranscriptDec 20, 2021
- Q3 2021 Novo Nordisk A/S Earnings Presentation (London-Based Investors) TranscriptNov 04, 2021
- Q3 2021 Novo Nordisk A/S Earnings Call TranscriptNov 03, 2021$57.47 (+4.41%)Earnings
- Q2 2021 Novo Nordisk A/S Earnings Call (London-Based Investors) TranscriptAug 06, 2021$50.21 (-1.02%)Earnings
- Q2 2021 Novo Nordisk A/S Earnings Call TranscriptAug 04, 2021$50.06 (+8.89%)Earnings
- Novo Nordisk A/S R&D Investor Call TranscriptJun 28, 2021
- Novo Nordisk A/S Approval of Wegovy™ in the United States Investor Call TranscriptJun 07, 2021
- Novo Nordisk A/S to Discuss International Operations Call TranscriptMay 21, 2021
- Q1 2021 Novo Nordisk A/S Earnings Call (London-Based Investors) TranscriptMay 06, 2021$37.46 (+2.80%)Earnings
- Q1 2021 Novo Nordisk A/S Earnings Call TranscriptMay 05, 2021$36.44 (-0.12%)Earnings
- Novo Nordisk A/S Annual Shareholders Meeting TranscriptMar 25, 2021
- Q4 2020 Novo Nordisk A/S Earnings Call (London-Based Investors) TranscriptFeb 05, 2021$35.97 (-0.26%)Earnings
- Q4 2020 Novo Nordisk A/S Earnings Call TranscriptFeb 03, 2021$36.12 (+1.29%)Earnings
- Novo Nordisk A/S at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Novo Nordisk A/S to Announce the Decision to Enter the Phase 3 Development in Alzheimer's Disease with Oral Semaglutide Call TranscriptDec 16, 2020
- Novo Nordisk A/S ESG Conference Call TranscriptNov 30, 2020
- Q3 2020 Novo Nordisk A/S Earnings Call (London-Based Investors) TranscriptNov 02, 2020$32.08 (+2.20%)Earnings
- Q3 2020 Novo Nordisk A/S Earnings Call TranscriptOct 30, 2020$31.39 (-7.12%)Earnings
- Novo Nordisk A/S to Discuss Updated 2020 Outlook Call TranscriptOct 09, 2020
- Q2 2020 Novo Nordisk A/S Earnings Call (London-Based Investors) TranscriptAug 07, 2020$31.82 (-1.64%)Earnings
- Q2 2020 Novo Nordisk A/S Earnings Call TranscriptAug 06, 2020$32.35 (-1.64%)Earnings
- Novo Nordisk A/S Virtual R&D Investor Call (Q&A) TranscriptJun 19, 2020
- Novo Nordisk A/S Virtual R&D Investor Presentation TranscriptJun 19, 2020
- Novo Nordisk A/S at UBS Global Healthcare Conference (Virtual) TranscriptMay 20, 2020
- Q1 2020 Novo Nordisk A/S Earnings Presentation TranscriptMay 07, 2020
- Q1 2020 Novo Nordisk A/S Earnings Call TranscriptMay 06, 2020$31.5 (+1.34%)Earnings
- Novo Nordisk A/S Annual Shareholders Meeting TranscriptMar 26, 2020
- Q4 2019 Novo Nordisk A/S Earnings Presentation TranscriptFeb 06, 2020
- Q4 2019 Novo Nordisk A/S Earnings Call TranscriptFeb 05, 2020$32.38 (+5.59%)Earnings
- Novo Nordisk A/S at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Novo Nordisk A/S Capital Markets Day TranscriptNov 20, 2019
- Dicerna Pharmaceuticals Inc to Discuss Collaboration with Novo Nordisk A/S Conference Call TranscriptNov 18, 2019
- Q3 2019 Novo Nordisk A/S Earnings Presentation TranscriptNov 04, 2019
- Q3 2019 Novo Nordisk A/S Earnings Call TranscriptNov 01, 2019$27.92 (+2.33%)Earnings
- Novo Nordisk A/S to Discuss Rybelsus® US Approval Call TranscriptSep 23, 2019
- Q2 2019 Novo Nordisk A/S Earnings Presentation TranscriptAug 12, 2019
- Q2 2019 Novo Nordisk A/S Earnings Call TranscriptAug 09, 2019$25.65 (+4.80%)Earnings
- Novo Nordisk A/S Investor and Analyst Event at ADA 2019 TranscriptJun 10, 2019
- Q1 2019 Novo Nordisk A/S Earnings Presentation TranscriptMay 07, 2019
- Q1 2019 Novo Nordisk A/S Earnings Call TranscriptMay 03, 2019$23.83 (-3.31%)Earnings
- Novo Nordisk A/S Annual Shareholders Meeting TranscriptMar 21, 2019
Novo Nordisk A/S Virtual R&D Investor Call (Q&A) Transcript
Jun 19, 2020 / 02:00PM GMT
Release Date Price:
$33.21
(+2.50%)
Karsten Munk Knudsen;S;Executive VP
Novo Nordisk A;CFO & Member of the Management Board
/- -
Welcome back to the Novo Nordisk virtual R&D investor presentation. Now we're on to the Q&A session. (Operator Instructions)
And then I will orchestrate the meeting from here.
Questions & Answers
Karsten Munk Knudsen;S;Executive VP
Novo Nordisk A;CFO & Member of the Management Board
/- -
(Operator Instructions) So we're ready to take the first question. And the first question goes to Martin Parkhøi from Danske Bank.
Martin ParkhÃ;i;S
Danske Bank A;Research Division - Senior Equity Analyst
¸ - / -
As Karsten said, it's Martin Parkhøi from Danske Bank. Firstly, I think is focused on the obesity mass. I guess, the Phase I trial that was in a loose combination. Could you talk a bit about the device for later-stage trials? We know it needs to be a dual-chamber device, but
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers